A Prospective, Single-arm, Phase II Study of Zanubrutinib in Combination With GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma
Latest Information Update: 17 Apr 2025
At a glance
- Drugs Zanubrutinib (Primary) ; Cyclophosphamide; Obinutuzumab; Prednisolone; Vindesine
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 15 Apr 2025 New trial record